Literature DB >> 28446433

In CLL, comorbidities and the complex karyotype are associated with an inferior outcome independently of CLL-IPI.

Gian Matteo Rigolin1, Maurizio Cavallari1, Francesca Maria Quaglia1, Luca Formigaro1, Enrico Lista1, Antonio Urso1, Emanuele Guardalben1, Carmine Liberatore1, Danilo Faraci1, Elena Saccenti1, Cristian Bassi2,3, Laura Lupini2,3, Maria Antonella Bardi1, Eleonora Volta1, Elisa Tammiso1, Aurora Melandri1, Massimo Negrini2,3, Francesco Cavazzini1, Antonio Cuneo1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28446433     DOI: 10.1182/blood-2017-03-772285

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  21 in total

Review 1.  On the architecture of translational research designed to control chronic lymphocytic leukemia.

Authors:  Michael Hallek
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials.

Authors:  Jennifer A Woyach
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

3.  Mapping comorbidity in chronic lymphocytic leukemia: impact of individual comorbidities on treatment, mortality, and causes of death.

Authors:  Emelie Curovic Rotbain; Carsten Utoft Niemann; Klaus Rostgaard; Caspar da Cunha-Bang; Henrik Hjalgrim; Henrik Frederiksen
Journal:  Leukemia       Date:  2021-02-18       Impact factor: 11.528

Review 4.  The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH).

Authors:  F Nguyen-Khac; A Bidet; A Daudignon; M Lafage-Pochitaloff; G Ameye; C Bilhou-Nabéra; E Chapiro; M A Collonge-Rame; W Cuccuini; N Douet-Guilbert; V Eclache; I Luquet; L Michaux; N Nadal; D Penther; B Quilichini; C Terre; C Lefebvre; M-B Troadec; L Véronèse
Journal:  Leukemia       Date:  2022-04-16       Impact factor: 12.883

5.  Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.

Authors:  Panagiotis Baliakas; Sabine Jeromin; Michalis Iskas; Anna Puiggros; Karla Plevova; Florence Nguyen-Khac; Zadie Davis; Gian Matteo Rigolin; Andrea Visentin; Aliki Xochelli; Julio Delgado; Fanny Baran-Marszak; Evangelia Stalika; Pau Abrisqueta; Kristina Durechova; George Papaioannou; Virginie Eclache; Maria Dimou; Theodoros Iliakis; Rosa Collado; Michael Doubek; M Jose Calasanz; Neus Ruiz-Xiville; Carolina Moreno; Marie Jarosova; Alexander C Leeksma; Panayiotis Panayiotidis; Helena Podgornik; Florence Cymbalista; Achilles Anagnostopoulos; Livio Trentin; Niki Stavroyianni; Fred Davi; Paolo Ghia; Arnon P Kater; Antonio Cuneo; Sarka Pospisilova; Blanca Espinet; Anastasia Athanasiadou; David Oscier; Claudia Haferlach; Kostas Stamatopoulos
Journal:  Blood       Date:  2019-01-02       Impact factor: 22.113

Review 6.  Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials.

Authors:  Jennifer A Woyach
Journal:  Blood       Date:  2019-11-21       Impact factor: 22.113

7.  The Chronic Lymphocytic Leukemia Comorbidity Index (CLL-CI): A Three-Factor Comorbidity Model.

Authors:  Max J Gordon; Andy Kaempf; Byung Park; Alexey V Danilov; Andrea Sitlinger; Geoffrey Shouse; Matthew Mei; Danielle M Brander; Tareq Salous; Brian T Hill; Hamood Alqahtani; Michael Choi; Michael C Churnetski; Jonathon B Cohen; Deborah M Stephens; Tanya Siddiqi; Xavier Rivera; Daniel Persky; Paul Wisniewski; Krish Patel; Mazyar Shadman
Journal:  Clin Cancer Res       Date:  2021-06-24       Impact factor: 12.531

8.  The combination of complex karyotype subtypes and IGHV mutational status identifies new prognostic and predictive groups in chronic lymphocytic leukaemia.

Authors:  Andrea Visentin; Laura Bonaldi; Gian Matteo Rigolin; Francesca Romana Mauro; Annalisa Martines; Federica Frezzato; Silvia Imbergamo; Edoardo Scomazzon; Stefano Pravato; Maria Antonella Bardi; Maurizio Cavallari; Eleonora Volta; Francesco Cavazzini; Maurizio Nanni; Ilaria Del Giudice; Monica Facco; Anna Guarini; Gianpietro Semenzato; Robin Foà; Antonio Cuneo; Livio Trentin
Journal:  Br J Cancer       Date:  2019-06-18       Impact factor: 7.640

9.  Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.

Authors:  Nina Kreuzberger; Johanna Aag Damen; Marialena Trivella; Lise J Estcourt; Angela Aldin; Lisa Umlauff; Maria Dla Vazquez-Montes; Robert Wolff; Karel Gm Moons; Ina Monsef; Farid Foroutan; Karl-Anton Kreuzer; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2020-07-31

Review 10.  Biological significance and prognostic/predictive impact of complex karyotype in chronic lymphocytic leukemia.

Authors:  Maurizio Cavallari; Francesco Cavazzini; Antonio Cuneo; Gian Matteo Rigolin; Antonella Bardi; Eleonora Volta; Aurora Melandri; Elisa Tammiso; Elena Saccenti; Enrico Lista; Francesca Maria Quaglia; Antonio Urso; Michele Laudisi; Elisa Menotti; Luca Formigaro; Melissa Dabusti; Maria Ciccone; Paolo Tomasi; Massimo Negrini
Journal:  Oncotarget       Date:  2018-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.